Results 21 to 30 of about 34,712 (291)

Cost-effectiveness and efficacy of combined dexamethasone–metoclopramide versus ondansetron in the prevention of postoperative nausea and vomiting in women undergoing myomectomy under spinal anesthesia

Bali Journal of Anesthesiology, 2019
Background: Postoperative nausea and vomiting (PONV) is a common complication following surgery under spinal anesthesia. The aim of this study was to compare the efficacy and cost-effectiveness of metoclopramide–dexamethasone combination with ondansetron
T A Ogbo, I T Ekwere, Kingsley Ufuoma Tobi, N P Edomwonyi   +3 more
doaj   +1 more source

Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: A nested case-control study

Wellcome Open Research, 2018
Background: Although nausea and vomiting are very common in pregnancy, their pathogenesis is poorly understood. We tested the hypothesis that circulating growth and differentiation factor 15 (GDF15) concentrations in early pregnancy, whose gene is ...
C. Petry, K. Ong, K. Burling, P. Barker, S. Goodburn, J. Perry, C. Acerini, I. Hughes, R. Painter, G. Afink, D. Dunger, S. O’Rahilly   +11 more
semanticscholar   +1 more source

The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature

BMC Palliative Care, 2019
Background Olanzapine is an atypical antipsychotic that has affinity for many central nervous system receptors. Its efficacy is supported by several studies in the prevention and treatment of chemotherapy-induced nausea and vomiting.
G. Saudemont, C. Prod’homme, Arlette Da Silva, S. Villet, M. Reich, N. Penel, V. Gamblin   +6 more
semanticscholar   +1 more source

Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines

Supportive Care in Cancer, 2019
PurposeRadiation-induced nausea and vomiting (RINV) can affect 50–80% of patients undergoing radiotherapy and negatively impacts quality of life. This review aimed to compare the most recent RINV antiemetic guidelines produced by the Multinational ...
Erin McKenzie, Pearl Zaki, S. Raman, R. Olson, Thomas McFarlane, C. DeAngelis, Stephanie Chan, W. Pidduck, Yasmeen Razvi, A. Bushehri, E. Chow   +10 more
semanticscholar   +1 more source

Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis.

The Oncologist, 2018
BACKGROUND It is important to control chemotherapy-induced nausea and vomiting (CINV) to maintain dose intensity and patients' quality of life. The National Comprehensive Cancer Network guidelines suggest combination therapy of antiemetic agents.
Takamichi Yokoe, T. Hayashida, A. Nagayama, Ayako Nakashoji, Hinako Maeda, T. Seki, Maiko Takahashi, T. Takano, T. Abe, Y. Kitagawa   +9 more
semanticscholar   +1 more source

Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas

Frontiers in Nutrition, 2018
BackgroundBone and soft tissue sarcomas are commonly treated with consecutive-day chemotherapy regimens consisting of multiple anticancer agents. Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of these regimens and may result
Yuta Hori, Yuta Hori, Akio Sakamoto, Takashi Goto, Syouji Ando, Manato Yamashita, Masayo Shimomura, Takuji Uemura   +7 more
doaj   +1 more source

Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting: A Review to Identify the Best Way to Administer the Drug

Current Oncology, 2022
Common treatment methods for malignant tumors include surgery, chemotherapy, radiotherapy, immunotherapy, targeted therapy, etc., among which chemotherapy plays an important role.
Xiao-Ling Zhang, Jie-Er Ying
doaj   +1 more source

Ondansetron induced torsades de pointes

Clinical Case Reports, 2019
A single dose of oral Ondansetron can precipitate torsades de pointes and other arrhythmias in patients with risk factors that may prolong QTc interval.
Eshan Patel, Danielle Rosemond, Ashwad Afzal   +2 more
doaj   +1 more source

Adherence to guidelines on prophylaxis of chemotherapy-induced nausea and vomiting in the National Cancer Institute, Sudan

South African Journal of Oncology, 2017
Objective: To evaluate the adherence to American Society of Clinical Oncology (ASCO) guidelines for antiemetic prophylaxis of chemotherapy-induced nausea and vomiting and assess the outcomes of the prescribed antiemetic drugs. Methods: This prospective,
Moawia M.A. Elhassan, Arwa A.S.A. Ali, Mohamed O.M. Elmustafa   +2 more
doaj   +1 more source

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients

Al-Mustansiriyah Journal of Pharmaceutical Sciences, 2023
Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic.
Ghufran salah ahmed, khadim ali khadim2, nabeel mudheher talib   +2 more
doaj   +1 more source